Uterine neoplasms, version 1.2014 Journal Article


Authors: Koh, W. J.; Greer, B. E.; Abu-Rustum, N. R.; Apte, S. M.; Campos, S. M.; Chan, J.; Cho, K. R.; Cohn, D.; Crispens, M. A.; DuPont, N.; Eifel, P. J.; Fader, A. N.; Fisher, C. M.; Gaffney, D. K.; George, S.; Han, E.; Huh, W. K.; Lurain, J. R. 3rd; Martin, L.; Mutch, D.; Remmenga, S. W.; Reynolds, R. K.; Small, W. Jr; Teng, N.; Tillmanns, T.; Valea, F. A.; McMillian, N.; Hughes, M.
Article Title: Uterine neoplasms, version 1.2014
Abstract: Adenocarcinomaof the endometrium (also known as endometrial cancer or more broadly as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the female genital tract in the United States. An estimated 49,560 new uterine cancer cases will occur in 2013, with 8190 deaths resulting from the disease. Uterine sarcomas (stromal/mesenchymal tumors) are uncommon malignancies, accounting for approximately 3% of all uterine cancers. The NCCN Guidelines for Uterine Neoplasms describe malignant epithelial carcinomas and uterine sarcomas; each of these major categories contains specific histologic groups that require different management. This excerpt of these guidelines focuses on earlystage disease. © JNCCN-Journal of the National Comprehensive Cancer Network.
Keywords: cancer chemotherapy; cancer surgery; cancer risk; united states; cancer adjuvant therapy; cancer radiotherapy; cancer staging; antineoplastic agent; cancer diagnosis; endometrium carcinoma; endometrium cancer; practice guideline; oncology; clinical evaluation; uterus cancer; uterus sarcoma; hormone substitution; female genital system; human; article
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 12
Issue: 2
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2014-02-01
Start Page: 248
End Page: 280
Language: English
PROVIDER: scopus
PUBMED: 24586086
DOI/URL:
Notes: Export Date: 1 August 2014 -- Source: Scopus
Citation Impact
MSK Authors
Related MSK Work